awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38635790-08B05746-9CC2-4E3F-A9F2-17DFC0A20ADD
Q38635790-08B05746-9CC2-4E3F-A9F2-17DFC0A20ADD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38635790-08B05746-9CC2-4E3F-A9F2-17DFC0A20ADD
Synthetic investigational new drugs for the treatment of tuberculosis.
P2860
Q38635790-08B05746-9CC2-4E3F-A9F2-17DFC0A20ADD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38635790-08B05746-9CC2-4E3F-A9F2-17DFC0A20ADD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27aa767650f94b50418ac4c2056c7334237b76c8
P2860
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.